SCHEMBL27738294

SCHEMBL27738294

Nc1ccc(OS(=O)(=O)Cc2c(Cl)cccc2Cl)cc1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A1 P22736 1/20 0.38
▸ KMT2A Q03164 1/20 0.36
▸ HTT P42858 1/20 0.35
▸ CA1 P00915 3/20 0.35
▸ CA2 P00918 3/20 0.35
▸ CA9 Q16790 3/20 0.35
▸ NFE2L2 Q16236 2/20 0.35
▸ AKR1B1 P15121 2/20 0.34
▸ ALPL P05186 1/20 0.33
▸ ALPI P09923 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ ALOX15 P16050 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ DPP4 P27487 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27717231 0.84 HTT (0.42) KMT2AHTTALDH1A1CYP3A4ALOX15
SCHEMBL543840 0.77 TUBB4A (0.44) NR4A1HTTCA1CA2CA9
SCHEMBL3099735 0.73 SMN1; SMN2 (0.53) NR4A1KMT2AALDH1A1SMN1; SMN2TDP1
SCHEMBL11846316 0.73 F2 (0.44) NR4A1KMT2ATDP1
SCHEMBL11850296 0.71 TUBB4A (0.40) NR4A1KMT2AHTTCA1CA2
SCHEMBL11843618 0.69 TDP1 (0.49) ALDH1A1CYP3A4ALOX15TSHRSMN1; SMN2
SCHEMBL11849091 0.67 APEX1 (0.67) NR4A1KMT2AHTTCA1CA2
SCHEMBL10900544 0.67 NR4A1 (0.52) NR4A1KMT2ACA1CA2CA9
SCHEMBL6380044 0.66 TAAR1 (0.46) KMT2ACA1CA2CA9AKR1B1
SCHEMBL1272049 0.66 RECQL (0.46) KMT2AHTTAKR1B1ALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101273019-A Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as C-Met inhibitors AVENTIS PHARMA SA (FR) 2008-09-24 — — CN disclosed
Send feedback